Fibryga’s New FDA Approval: A Triumph For Fibrinogen Care | |
The FDA has expanded the indication of Octapharma’s Fibryga to include AFD. This makes it the first and only on-demand, virus-inactivated, human plasma-derived fibrinogen concentrate approved for this indication. Fibryga’s FDA approval for AFD introduces a groundbreaking on-demand fibrinogen treatment, revolutionizing care for severe bleeding and fibrinogen deficiencies. To learn more read this blog. | |
Related Link: Click here to visit item owner's website (0 hit) | |
Target State: California Target City : All Cities Last Update : Sep 19, 2024 8:20 AM Number of Views: 47 | Item Owner : writerjulie Contact Email: Contact Phone: (None) |
Friendly reminder: Click here to read some tips. |